In a woman with hypogonadotropic hypogonadism who is taking estradiol and progesterone and wishes to become pregnant, how can she induce a withdrawal bleed to start her menstrual cycle before beginning fertility treatment?

Inducing Withdrawal Bleeding in Hypogonadotropic Hypogonadism Before Fertility Treatment

To induce a withdrawal bleed before starting fertility treatment, administer oral micronized progesterone 300 mg daily for 10 days, which will trigger withdrawal bleeding in approximately 90% of women within 7 days of completing the course 1.

Rationale and Evidence

The goal here is straightforward: you need to induce a withdrawal bleed to "reset" the endometrium before initiating ovulation induction therapy. Since she's already on estradiol and progesterone maintenance therapy, her endometrium should be adequately primed with estrogen.

Progesterone Withdrawal Protocol

The optimal approach is:

• Oral micronized progesterone 300 mg daily for 10 days 2, 1
• Expect withdrawal bleeding within 7 days after the last dose in 90% of cases 1
• The 300 mg dose is significantly more effective than 200 mg (90% vs 58% bleeding response) 1

The FDA-approved indication for progesterone capsules specifically includes secondary amenorrhea, where 10 days of therapy at 300 mg daily resulted in 80% of women experiencing withdrawal bleeding within 7 days 2. A multicenter study confirmed that 73.8-76.8% of women with secondary amenorrhea achieved withdrawal bleeding with this regimen 2.

Important Considerations

Ensure adequate estrogen priming first: The patient must have sufficient endogenous or exogenous estrogen exposure for progesterone withdrawal to work effectively 1. Since she's already taking estradiol, this requirement should be met. However, if she's been on continuous combined therapy (estradiol + progesterone daily), you may need to:

1. Continue her estradiol at current dose
2. Stop progesterone for at least 2 weeks to allow endometrial proliferation
3. Then administer the 10-day progesterone course to induce withdrawal

Alternative if already on sequential therapy: If she's already taking cyclic progesterone (12-14 days per month), simply ensure she completes a full cycle and waits for withdrawal bleeding before proceeding to fertility treatment 3.

Transition to Fertility Treatment

Once withdrawal bleeding occurs, the timing for initiating fertility treatment depends on the specific protocol:

For pulsatile GnRH therapy (first-line when available): This is the gold standard for hypogonadotropic hypogonadism, achieving 96% cumulative conception rates after 6 cycles with minimal multiple pregnancy risk (8.3%) 4. However, GnRH is currently unavailable in the United States 4.

For gonadotropin therapy (when GnRH unavailable): Start on cycle day 2-3 after the induced withdrawal bleed. Use preparations containing both FSH and LH activity, as women with hypogonadotropic hypogonadism require LH for adequate estradiol response 4. Expect 72% cumulative conception after 6 cycles, though with higher multiple gestation risk (14.8%) 4.

Critical pitfall to avoid: Do not use clomiphene citrate as first-line therapy in true hypogonadotropic hypogonadism. Women with this condition lack sufficient endogenous gonadotropin secretion to respond to opening the estrogen negative feedback loop 4. Clomiphene may only work if she has sufficient endogenous estrogen levels and some residual gonadotropin function 4.

Side Effects and Monitoring

The 300 mg progesterone dose has a favorable side effect profile similar to placebo, with the most common being fatigue (8%), headache (16%), and dizziness (24%) 2. These are generally well-tolerated for the short 10-day course 1.

If withdrawal bleeding does not occur within 7-10 days after completing progesterone: This suggests inadequate estrogen priming. Increase her estradiol dose (e.g., to 2 mg daily oral or 100 μg transdermal patches) for 2-4 weeks, then repeat the progesterone withdrawal 3.